세계의 가상 종양학 시장 : 컴포넌트별, 암 유형별, 용도별, 최종사용자별, 지역별

Virtual Oncology Market is estimated to be valued at USD 4.73 Bn in 2025 and is expected to reach USD 14.98 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.9% from 2025 to 2032.

Virtual oncology is an emerging field in healthcare that utilizes technology to provide remote cancer care and support services. It encompasses various digital solutions such as telemedicine, virtual consultations, remote monitoring, and personalized treatment plans. The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience.

With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained significant traction in recent years. This approach offers several benefits, including reduced travel time and costs for patients, improved access to expert opinions, and the ability to monitor patients' health remotely. It also allows for more personalized treatment options based on individual patient needs and preferences.

Market Dynamics:

The virtual oncology market is expected to witness substantial growth in the coming years, primarily driven by factors such as the increasing prevalence of cancer, the growing need for remote healthcare services, and advancements in technology. Additionally, the COVID-19 pandemic has further accelerated the adoption of virtual oncology solutions as hospitals and clinics focus on reducing in-person visits and minimizing the risk of infections.

However, there are certain challenges that may restrain market growth. Concerns regarding data security and patient privacy, along with regulatory barriers, pose significant hurdles for market players. Moreover, the lack of skilled healthcare professionals proficient in virtual technologies and the high costs associated with implementing such systems may limit the market's expansion.

Nevertheless, the virtual oncology market presents several opportunities for both existing and new market players. The increasing adoption of artificial intelligence (AI) and machine learning algorithms in virtual oncology can help improve diagnosis, treatment planning, and patient monitoring. Additionally, collaborations between technology companies and healthcare providers to develop innovative solutions and enhance patient engagement are expected to drive market growth.

Key Features of the Study:

• This report provides in-depth analysis of the global virtual oncology market, including market size (in US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global virtual oncology market based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
• Key companies covered in this study include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical
• Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
• The global virtual oncology market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders will benefit from the various strategy matrices used in analyzing the global virtual oncology market, which will aid in decision-making processes.

Virtual Oncology Market Segmentation:

• Virtual Oncology Market, By Component
  • Software
  • Service
  • Hardware
• Virtual Oncology Market, By Cancer Type
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Bladder Cancer
  • Others (Pancreatic, Ovarian etc.)
• Virtual Oncology Market, By Application
  • Precision Medicine
  • Patient Care Management
  • Research & Development
  • Clinical Trials
  • Diagnosis & Treatment Decision Making
  • Data Management
  • Others (Billing Management, Regulatory Compliance etc.)
• Virtual Oncology Market, By End User
  • Hospitals & Diagnostic Imaging Centers
  • Academic Institutions & Research Centers
  • Pharma & Biotech Companies
  • Contract Research Organizations (CROs)
  • Others (Reference Laboratories, Pharmacies etc.)
• Virtual Oncology Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Flatiron Health
  • McKesson Corporation
  • Cerner Corporation
  • Koninklijke Philips N.V.
  • Siemens Healthcare Private Limited
  • Crisp
  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • C-TAC Health
  • Oscar Health
  • NXGN Management, LLC
  • Epic Systems Corporation
  • Optum, Inc
  • CureMatch, Inc.
  • Oncora Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Virtual Oncology, By Component
  • Market Virtual Oncology, By Cancer Type
  • Market Virtual Oncology, By Application
  • Market Virtual Oncology, By End User
  • Market Virtual Oncology, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising prevalence of cancer globally
  • Restraints
• Data privacy and security concerns
  • Opportunities
• Emerging markets exhibit significant growth potential
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Virtual Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Virtual Oncology Market , By Component, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Service
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hardware
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Virtual Oncology Market, By Cancer Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Breast Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Prostate Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Liver Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bladder Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Pancreatic, Ovarian etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Virtual Oncology Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Precision Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Patient Care Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research & Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clinical Trials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnosis & Treatment Decision Making
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Data Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Billing Management, Regulatory Compliance etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Virtual Oncology Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals & Diagnostic Imaging Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Academic Institutions & Research Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pharma & Biotech Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Reference Laboratories, Pharmacies etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Virtual Oncology Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • South Africa
    • Central Africa

10. Competitive Landscape

• Flatiron Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• McKesson Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cerner Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens Healthcare Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Crisp
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Varian Medical Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Elekta AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Accuray Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• C-TAC Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oscar Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NXGN Management, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Epic Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Optum, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AI
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CureMatch, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Oncora Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us